RxDoctor Payments Data

Chunxia Zhang

Corneal and Contact Management · Kensington, MDNPI 1679674576

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 45.1% of the total. Reporting peaked in 2024 at $436 and has fallen 53.8% since, to $201 in 2025.

$1,213in general payments, 2019–2025

Across 19 payments — averaging $63.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$547
  • LKC Technologies, Inc.$178
  • Biotissue Holdings Inc.$140
  • Oyster Point Pharma, Inc.$137
  • Alcon$99
  • Sight Sciences, Inc.$79
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$1,19699%
  • Gifts$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few corneal and contact management providers in Marylandto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,802
Medicare patients
19
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other corneal and contact management in Kensington

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →